Reported about 2 months ago
Shares of Bavarian Nordic, a Danish vaccine developer, soared following the WHO's declaration of a fast-spreading mpox outbreak in Africa as a global health emergency. The company can provide 10 million doses of its vaccine by 2025, while other health stocks also saw significant gains. Analysts suggest caution among investors as the situation evolves, highlighting the potential for the mpox outbreak to resonate with concerns from the COVID-19 pandemic.
Source: YAHOO